• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

REGULATION OF TGF-β AND ITS SIGNAL MOLECULE, SMAD FOR ATTENUATION OF PERITONEAL FIBROSIS.

Research Project

Project/Area Number 12671058
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKurume University

Principal Investigator

KOHNO Keisuke  KURUME UNIVERSITY SCHOOL OF MEDICINE, DEPARTMENT OF NEPHROLOGY, ASSISTANT PROFESSOR, 医学部, 助手 (70258416)

Co-Investigator(Kenkyū-buntansha) OKUDA Seiya  KURUME UNIVERSITY SCHOOL OF MEDICINE, PROFESSOR, 医学部, 教授 (80158823)
TAMAKI Kiyoshi  KURUME UNIVERSITY SCHOOL OF MEDICINE, ASSISTANT PROFESSOR, 医学部, 講師 (10312141)
Project Period (FY) 2000 – 2001
KeywordsGrowth factor / TGF-β / Smad / peritoneal fibrosis / Adenovirus-vector / CAPD / Smad binding element
Research Abstract

TGF-β1 plays a pathological role in fibrotic and sclerotic diseases including peritoneal fibrosis. Smads have been identified as pivotal components in TGF-** intracellular signaling. The present study was carried out to investigate TGF-β-induced Smad activation in cultured cells and experimental peritoneal firotic diseases in rodents. In cultured! cells, TGF-β1 induced phosphorylation of Smad2.Gene transfer using Adenovirus-vector, double-overexpression of Smad2 and Smad4 induced TGF-I3istimulated plasminogen activator inhibitor-1 (PM-i) expression more than overexpression of each Smad alone. Furthermore, overexpression of Smad7, one of inhibitory Smads, but not Smd6 reversed TGF- β1-inhibited cell proliferation by inhibiting Smad2 phosphorylation. In addition, TGF-β1 or high glucose condition induced the expression of SBE (Smad-binding element)-luciferase activity, which was reversed by the transfection-with Smad2 mutant or inhitory Smad7.
In experimental peritoneal fibrosis using iodine, progressive peritoneal thickness was observed. This thickness was due to the accumulation of matrix proteins. We tried gene transfer of Smad protein into these animal models. But the peritonea! fibrosis was not reproducible. We are now under investigation to make reproducible model of peritoneal fibrosis. However, our results indicate the possibility that modulation of Smad activity may attenuate the development of peritoneal fibrosis and sclerosis.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Ueda S, Kono K, et al.: "Overexpression of Smad7 not Smad6 inhibits TGF-b actions in mesangial cells"A.J.Soc.Nephrol.. 623A. (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Haramaki R, Tamaki K, et al.: "Steroid therapy and urinary transforming growth factor-betal in IgA nephropathy"Am.J.Kidney.Dis.. 38(6). 1191-1198 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato S, Tamaki K, et al.: "Ectopic expression of Smad7 inhibits transforming growth factor-beta responses in vascular smooth muscle cells"Life Sci.. 69,22. 2641-2652 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tamaki K, et al.: "Chinese herbs nephropathy : a variant form in Japan"Intern Med.. 40(4). 267-268 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tamaki K, Okuda S;: "Role of TGB-β in the progression of renal fibrosis"Indian review of renal fibrosis. (印刷中). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 玉置清志: "糸球体病変と成長因子、ケモカイン"内科. 87(6). 1211-1217 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 奥田誠也: "腎と透析、51、臨時増刊"糖尿病性腎症におけるTGF-βの役割. 162-167 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tamai O, Tamaki K, Okuda S et al: "Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis."Kidney Int.. 59. 471-480 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Haramaki R, Tamaki K. et al.: "Steroid therapy and urinary transforming growth factor-betal in IgA nephropathy."Am J Kidney Dis.. 38. 1191-1198 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kashiwagi M, S Tamaki K.et al: "Locally activated reninangiotensin system associated TGF-β1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats."J Am Soc Nephrol. 11. 616-624 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kato S, Tamaki K. et al.: "Ectopic expression of Smad? inhibits transforming growth factor-beta responses in vascular smooth muscle cells"Life Sci. 69. 2641-2652 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda S, Kohno K, et al: "Overexpression of Smad7 not Smad6 inhibits TGF-β actions in mesangial cells"J A Soc Nephrol. 12. 623A (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Haramaki R, Tamaki K. Okuda S et al: "Steroid therapy and urinary transforming growth factor-b1 in IgA nephropathy."J Am Soc Nephrology. 11. 62 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi